Hong Kong-Singapore travel bubble: will Sinovac’s efficacy against Delta coronavirus variant be the next stumbling block?
- While city state points to lack of data about vaccine’s worth against new variants, Hong Kong authorities have defended the Chinese-produced jabs
- Three new imported cases confirmed on Thursday, meanwhile, extending streak without a local infection to 31 days
Hong Kong, where about 701,700 residents have taken two doses of the Sinovac jab, confirmed three imported infections on Thursday – one each from Russia, the Philippines and Britain – marking 31 straight days without a local case. The additions took the city’s overall tally to 11,948 cases with 212 related deaths.
In a separate development, the Centre for Health Protection said on Thursday evening it was investigating a suspected re-positive case involving a staff member, 39, at the Kazakh consulate. He arrived from Kazakhstan via Bangkok on Monday.
The sample he submitted on Wednesday was positive for Covid-19 at a private lab, but the same specimen tested indeterminate at a Department of Health lab. The centre said he was confirmed as infected in Kazakhstan last month and it was following up with the country’s health authorities.